SCHEMBL1675320

SCHEMBL1675320

CCOC(=O)c1ccoc1-c1ccc2ncnc(N(C)c3ncc[nH]3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 5/20 0.41
CLK4 Q9HAZ1 11/20 0.39
DYRK1A Q13627 4/20 0.39
CLK2 P49760 3/20 0.39
DYRK1B Q9Y463 3/20 0.39
NUDT1 P36639 1/20 0.37
CYP1A2 P05177 8/20 0.37
CYP3A4 P08684 8/20 0.37
LMNA P02545 7/20 0.37
CYP2D6 P10635 7/20 0.37
CYP2C19 P33261 7/20 0.37
ALDH1A1 P00352 6/20 0.37
MAPK1 P28482 5/20 0.37
TSHR P16473 5/20 0.37
USP2 O75604 4/20 0.37
HSD17B10 Q99714 4/20 0.37
HIF1A Q16665 3/20 0.37
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675202 0.82 CLK1 (0.44) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL1675115 0.82 CLK1 (0.61) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL1675323 0.79 CLK4 (0.53) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL1675140 0.76 CLK1 (0.70) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL1675295 0.71 CLK4 (0.55) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL1675204 0.70 CLK1 (0.71) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL693 0.65 TSHR (0.47) CYP3A4LMNACYP2C19ALDH1A1TSHR
SCHEMBL1675336 0.64 CLK1 (0.68) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL1675222 0.64 CLK1 (0.67) CLK1CLK4DYRK1ACLK2DYRK1B
SCHEMBL3504414 0.63 TSHR (0.56) CYP3A4LMNACYP2C19ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed